Bristol-Myers Squibb Company
| Location | Plainsboro, New Jersey |
| Asset Size | >$1 billion |
| Number of Participants | >11,000 |
| Business | Pharmaceuticals |
| Participation Rate | 95% |
| Avg Deferral Rate | 10.00% |
| Number of Funds | 14 |
| Investment Review | Annually |
| Fee Review | 3 years |
| Fee Equalization | N/A |
| Auto-Enrollment Rate | 6% |
| Auto-Escalation Rate | 1% |
| Re-Enrollment | No |
| Default Investment | Target-date (active) |
| Ret Income Offering | None |
| Vesting Period | 5 years |
| Match Rate | 100% of first 6% of salary |
| % Receiving Full Match | >90% |
| True-Up Match | No |
| Financial Education | |
| Saving/budgeting | x |
| Investing strategies | x |
| College saving | x |
| Credit/debt mgmt | x |
| Tax/estate planning | x |
| Retiree health costs/savings options | x |
| Provider | Fidelity Investments |
Get the latest news daily